EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,203,000 | +2.3% | 75,000 | 0.0% | 0.06% | -8.8% |
| Q3 2022 | $1,176,000 | -24.7% | 75,000 | 0.0% | 0.07% | -25.3% |
| Q2 2022 | $1,562,000 | +65.6% | 75,000 | +44.8% | 0.09% | +213.8% |
| Q2 2021 | $943,000 | -37.2% | 51,779 | -22.1% | 0.03% | -32.6% |
| Q1 2021 | $1,501,000 | -61.2% | 66,460 | -66.2% | 0.04% | -94.4% |
| Q4 2018 | $3,870,000 | +118.4% | 196,755 | +96.8% | 0.77% | +107.2% |
| Q3 2018 | $1,772,000 | +100.0% | 100,000 | +150.0% | 0.37% | -28.7% |
| Q1 2018 | $886,000 | -63.6% | 40,000 | -50.0% | 0.52% | -48.6% |
| Q4 2017 | $2,432,000 | +98.4% | 80,000 | +58.1% | 1.02% | +183.6% |
| Q3 2017 | $1,226,000 | – | 50,600 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |